Clinical Trial Update: Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF [Phase 1]

View source ↗

Summary

Phase 1 study evaluating mobilization of autologous peripheral blood stem cells using interleukin-2 and GM-CSF; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis
• Hodgkin Lymphoma
• Leukemia
• Multiple Myeloma
• Non-hodgkin Lymphoma
• Waldenström Macroglobulinemia

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Non-Hodgkin's Lymphoma, Hodgkin's Disease | Phase 1 | Status: COMPLETED